Cytokinesproduction by blood immune cells in patients of different age groups with invasive ductal carcinoma of no special type and lymphatic metastases ; Продукция цитокинов иммунокомпетентными клетками крови у больных инвазивной карциномой молочной железы неспецифического типа в различных возрастных группах при лимфогенном метастазировании

Συγγραφείς: K. I. Davletova, E. S. Mikhaylova, N. A. Varaksin, L. P. Zhurakovsky, A. V. Proskura, S. V. Sidorov, A. I. Autenshlyus, К. И. Давлетова, Е. С. Михайлова, Н. А. Вараксин, И. П. Жураковский, А. В. Проскура, С. В. Сидоров, А. И. Аутеншлюс

Πηγή: Medical Immunology (Russia); Том 21, № 6 (2019); 1115-1126 ; Медицинская иммунология; Том 21, № 6 (2019); 1115-1126 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2019-6

Θεματικοί όροι: лимфогенное метастазирование, blood immune cells, polyclonal activators, breast cancer, invasive ductal carcinoma of no special type, lymph nodes metastasis, иммунокомпетентные клетки крови, поликлональные активаторы, рак молочной железы, инвазивная карцинома молочной железы неспецифического типа

Περιγραφή αρχείου: application/pdf

Relation: https://www.mimmun.ru/mimmun/article/view/1764/1208; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4965; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4966; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4967; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4968; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4969; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4970; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4971; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4972; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4973; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4974; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4975; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4976; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4977; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4978; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4979; Соснина А.В., Великая Н.В., Вараксин Н.А., Гришаев М.П., Аутеншлюс А.И. Роль цитокинов в патогенезе злокачественных новообразований. Новосибирск: Офсет, 2014. 128 с.; Cetean S., Cainap C., Constantin A., Cainap S., Gherman A., Oprean L., Hangan A., Oprean R. The importance of the granulocyte-colony stimulating factor in oncology. Clujul Med., 2015, Vol. 88, no. 4, pp. 468-472.; Coppe J., Desprez P., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol., 2010, Vol. 5, pp. 99-118.; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, Vol. 365, no. 1687, p. 717.; Gameiro C.M., Romao F., Castelo-Branco C. Menopause and aging: changes in the immune system - a review. Maturitas, 2010, Vol. 67, no. 4, p. 316.; Garcla-Tunon I., Ricote M., Ruiz A.A., Fraile B., Paniagua R., Royuela M. Influence of IFN-gamma and its receptors in human breast cancer. BMC Cancer, 2007, Vol. 7, p. 158.; Giordano S.B., Gradishar W. Breast cancer: updates and advances in 2016. Curr. Opin. Obstet. Gynecol., 2017, Vol. 29, no. 1, pp. 12-17.; Gonzalez H., Hagerling C., Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes and Dev., 2018, Vol. 32, no. 19-20, pp. 1267-1284.; Herrera A.C., Panis C., Victorino V.J., Campos F.C., Colado-Simao A.N., Cecchini A.L., Cecchini R. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunol. Immunother., 2012, Vol. 61, no. 11, pp. 2193-201.; Keunhee O., Ok-Young L., Yeonju P., Myung W.S., Dong-Sup L. IL-1 p induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells. BMC Cancer, 2016, Vol. 16, no. 1, p. 724.; Li Z., Jiang J., Wang Z., Zhang J., Xiao M., Wang C., Lu Y., Qin Z. Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis. Cancer Res., 2008, Vol. 68, no. 21, p. 94.; Mauer J., Denson J.L., Bruning J.C. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol., 2015, Vol. 36, no. 2, pp. 92-101.; Nagini S. Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med. Chem., 2017, Vol. 17, no. 2, pp. 152-163.; Pfeilschifter J., Kbditz R., Pfoh M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev., 2002, Vol. 23, no. 1, pp. 90-119.; Szomolay B., Eubank T.D., Roberts R.D., Marsh C.B., Friedman A. Modeling the inhibition of breast cancer growth by GM-CSF. J. Theor. Biol., 2012, Vol. 303, no. 141 p. 51.; Todaro M., Lombardo Y., Francipane M.G., Alea M.P., Cammareri P., Iovino F., Di Stefano A.B., di Bernardo C., Agrusa A., Condorelli G., Walczak H., Stassi G. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ., 2008, Vol. 4, no. 762, p. 72.; Tortorella C., Simone O., Piazzolla G., Stella I., Antonaci S. Age-related impairment of GM-CSF-induced signalling in neutrophils: role of SHP-1 and SOCS proteins. Ageing Res. Rev., 2007, Vol. 6, no. 2, pp. 81-93.; Yazdkhasti M., Tourzani Z.M., Roozbeh N., Hasanpour V. Saeieh S.E., Abdi F. The association between diabetes and age at the onset of menopause: a systematic review protocol. Syst. Rev., 2019, Vol. 8, no. 1, p. 80.; https://www.mimmun.ru/mimmun/article/view/1764

Διαθεσιμότητα: https://www.mimmun.ru/mimmun/article/view/1764
https://doi.org/10.15789/1563-0625-2019-6-1115-1126